Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 22, 2021 07:30 ET | Source: Franchise Group, Inc.

Franchise Group, Inc.’s Liberty Tax Service to Anchor NextPoint Acquisition Corp.’s Diversified Financial Services Platform

• Franchise Group to Receive in Excess of $240 million of Consideration, Including $182 million of Cash • Franchise Group to Own at least 6.1 million Shares in NextPoint ORLANDO, Fla., Feb. 22,...
February 11, 2021 06:55 ET | Source: Myovant Sciences, Inc.

Myovant Sciences Announces Corporate Updates and Financial Results for Third Quarter of Fiscal Year 2020

ORGOVYX™ (relugolix) approved by the U.S. Food and Drug Administration (FDA) in December 2020 as the first and only oral GnRH receptor antagonist for adult patients with advanced prostate cancer;...
February 09, 2021 12:37 ET | Source: Jeffersonville Bancorp

Jeffersonville Bancorp Announces Fourth Quarter Earnings of $1,204,000 and Year to Date Earnings of $4,810,000; Declares Dividend of $0.15

JEFFERSONVILLE, N.Y., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Jeffersonville Bancorp, Inc. (OTCQB - JFBC) announced today fourth quarter net income of $1,204,000 or $0.28 per share compared to $1,045,000...
January 19, 2021 09:00 ET | Source: Heartland Express, Inc.

Heartland Express, Inc. Reports Revenues, Earnings and Record High Stockholders' Equity for the Fourth Quarter and Year Ended December 31, 2020

NORTH LIBERTY, Iowa, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Heartland Express, Inc. (Nasdaq: HTLD) announced today financial results for the quarter and year ended December 31, 2020. Three months...
November 12, 2020 07:00 ET | Source: Myovant Sciences, Inc.

Myovant Sciences Announces Corporate Updates and Financial Results for Second Quarter Fiscal Year 2020

FDA Priority Review of New Drug Application (NDA) for relugolix monotherapy tablet for advanced prostate cancer on track for decision by December 20, 2020 target action dateNDA for relugolix...
November 11, 2020 07:32 ET | Source: CANN-IS CAPITAL CORP.

Cann-Is Capital Corp. Provides Update on Qualifying Transaction with CWE European Holdings Inc.

TORONTO, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Cann-Is Capital Corp. (“Cann-Is” or the “Corporation”) (TSX-V: NIS.P) is pleased to provide certain updates from its press release dated September 23, 2020...
November 10, 2020 10:49 ET | Source: Jeffersonville Bancorp

Jeffersonville Bancorp Announces Third Quarter Earnings of $1,296,000 or $0.30 per share and Year to Date Earnings of $3,606,000 or $0.85 per share; Declares Dividend of $0.15

JEFFERSONVILLE, N.Y., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Jeffersonville Bancorp, Inc. (OTCQB - JFBC) announced today third quarter net income of $1,296,000 or $0.30 per share compared to $1,698,000...
October 16, 2020 09:00 ET | Source: Heartland Express, Inc.

Heartland Express, Inc. Reports Revenues and Earnings for the Third Quarter of 2020

NORTH LIBERTY, Iowa, Oct. 16, 2020 (GLOBE NEWSWIRE) -- Heartland Express, Inc. (Nasdaq: HTLD) announced today financial results for the three and nine months ended September 30, 2020. Three months...
August 11, 2020 11:50 ET | Source: Jeffersonville Bancorp

Jeffersonville Bancorp Announces Second Quarter Earnings of $1,264,000 or $0.30 per share and Year to Date Earnings of $2,310,000 or $0.55 per share; Declares Dividend of $0.15

JEFFERSONVILLE, N.Y., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Jeffersonville Bancorp, Inc. (OTCQB - JFBC) announced today second quarter net income of $1,264,000 or $0.30 per share compared to $2,086,000...
August 11, 2020 08:30 ET | Source: Myovant Sciences, Inc.

Myovant Sciences Announces Corporate Updates and Financial Results for First Quarter Fiscal Year 2020

New Drug Application (NDA) for relugolix monotherapy tablet in advanced prostate cancer accepted for Priority Review by the FDA with target action date of December 20, 2020NDA for relugolix...